Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 4
2008 3
2009 1
2010 1
2011 1
2012 3
2013 2
2014 4
2015 4
2016 6
2017 3
2019 1
2020 1
2021 6
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
Karner C, Anders I, Vejzovic D, Szkandera J, Scheipl S, Deutsch AJA, Weiss L, Vierlinger K, Kolb D, Kühberger S, Heitzer E, Habisch H, Zhang F, Madl T, Reininger-Gutmann B, Liegl-Atzwanger B, Rinner B. Karner C, et al. Among authors: vierlinger k. J Transl Med. 2023 Jan 29;21(1):54. doi: 10.1186/s12967-022-03843-4. J Transl Med. 2023. PMID: 36710341 Free PMC article.
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
Vetrano S, Bouma G, Benschop RJ, Birngruber T, Costanzo A, D'Haens GRAM, Frasca L, Hillenbrand R, Iversen L, Johansen C, Kaser A, Koenen HJPM, Noehammer C, Peyrin-Biroulet L, Raes J, Ricotti L, Rosenstiel P, Satagopam VP, Schreiber S, Vermeire S, Wollenberg A, Weidinger S, Ziemek D, Danese S; ImmUniverse Consortium. Vetrano S, et al. Front Immunol. 2022 Nov 9;13:1002629. doi: 10.3389/fimmu.2022.1002629. eCollection 2022. Front Immunol. 2022. PMID: 36439150 Free PMC article.
Strategies for validation and testing of DNA methylation biomarkers.
Noehammer C, Pulverer W, Hassler MR, Hofner M, Wielscher M, Vierlinger K, Liloglou T, McCarthy D, Jensen TJ, Nygren A, Gohlke H, Trooskens G, Braspenning M, Van Criekinge W, Egger G, Weinhaeusel A. Noehammer C, et al. Among authors: vierlinger k. Epigenomics. 2014;6(6):603-22. doi: 10.2217/epi.14.43. Epigenomics. 2014. PMID: 25531255 Review.
Characterization of the drugged human genome.
Lauss M, Kriegner A, Vierlinger K, Noehammer C. Lauss M, et al. Among authors: vierlinger k. Pharmacogenomics. 2007 Aug;8(8):1063-73. doi: 10.2217/14622416.8.8.1063. Pharmacogenomics. 2007. PMID: 17716238 Review.
A survey of tools for the analysis of quantitative PCR (qPCR) data.
Pabinger S, Rödiger S, Kriegner A, Vierlinger K, Weinhäusel A. Pabinger S, et al. Among authors: vierlinger k. Biomol Detect Quantif. 2014 Sep 6;1(1):23-33. doi: 10.1016/j.bdq.2014.08.002. eCollection 2014 Sep. Biomol Detect Quantif. 2014. PMID: 27920994 Free PMC article. Review.
Functional Analysis of Autoantibody Signatures in Rheumatoid Arthritis.
Milchram L, Fischer A, Huber J, Soldo R, Sieghart D, Vierlinger K, Blüml S, Steiner G, Weinhäusel A. Milchram L, et al. Among authors: vierlinger k. Molecules. 2022 Feb 21;27(4):1452. doi: 10.3390/molecules27041452. Molecules. 2022. PMID: 35209238 Free PMC article.
Designed SARS-CoV-2 receptor binding domain variants form stable monomers.
Klausberger M, Kienzl NF, Stadlmayr G, Grünwald-Gruber C, Laurent E, Stadlbauer K, Stracke F, Vierlinger K, Hofner M, Manhart G, Gerner W, Grebien F, Weinhäusel A, Mach L, Wozniak-Knopp G. Klausberger M, et al. Among authors: vierlinger k. Biotechnol J. 2022 May;17(5):e2100422. doi: 10.1002/biot.202100422. Epub 2022 Feb 3. Biotechnol J. 2022. PMID: 35078277 Free PMC article.
50 results